CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Pedro Sánchez-Aparicio

ORCID: 0000-0002-6511-6595↗

Public evidence

2 connected articles

Repeated Administration of the Cannabinoid WIN Alters the Isoflurane-Sparing Effect of Morphine and Dexmedetomidine.2023 · Europe PMC Minimum Alveolar Concentration of Isoflurane in Rats Chronically Treated with the Synthetic Cannabinoid WIN 55,212-2.2022 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Pedro Sánchez-Aparicio - Medical Cannabis Research Engine